Salute e Benessere

Neurocrine Biosciences's Crinecerfont is Set to Transform the Congenital Adrenal…

In the 7MM, the US accounted for the highest prevalent cases of congenital adrenal hyperplasia in 2023, with around 50% of the total prevalent cases across the 7MM; these numbers are expected to increase during the forecast period (2024–2034). In the 7MM, the US accounted for the highest prevalent cases of congenital adrenal hyperplasia in 2023, with around50%of the total prevalent cases across the 7MM; these numbers are expected to increase during the forecast period (2024–2034). ...
PR Newswire
30/09/2024

Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at…

In order to participate, please register in advancehere to obtain a local or toll-free phone number and your personal pin.A live webcast of the call will be available on Teva's website at:https://ir.tevapharm.com/Events-and-Presentations Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva's website. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global pharmaceutical leader with a category-defying...
Nasdaq GlobeNewswire
30/09/2024

Galapagos receives transparency notification from EcoR1 Capital

Mechelen, Belgium; 30 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from EcoR1 Capital LLC. Pursuant to Belgian transparency legislation 1, Galapagos received a transparency notification on 26 September 2024 on behalf of Mr. Oleg Nodelman and EcoR1 Capital LLC, who notified us that EcoR1 Capital LLC holds 7,094,049 of Galapagos' voting rights, consisting of 6,939,043 ordinary shares and 155,006 American...
Nasdaq GlobeNewswire
30/09/2024

AB Science announces a slight delay in the publication of its 2024 half-year…

PRESS RELEASEAB SCIENCE ANNOUNCES A SLIGHT DELAY IN THE PUBLICATION OF ITS 2024 HALF-YEAR FINANCIAL REPORTTHE COMPANY WILL PUBLISH ITS HALF-YEAR FINANCIAL REPORT FOR 2024 ON OCTOBER 7, 2024Paris, September 30 2024, 6.30pm CETAB Science SA(Euronext - FR0010557264 - AB) today announced that it has postponed the publication of its financial report for the first half of 2024, initially scheduled for 30 September 2024, to give the auditors time to complete their audit work...
Nasdaq GlobeNewswire
30/09/2024

Casino Group continues its transformation

Casino Group continues its transformationOn 24 April 2024, Casino Group launched a transformation plan to align its organisation with its new scope, centred on convenience retailing.Agreements have been signed with the trade unions in the 7 Group host companies concerned by the employment protection plan, and have been validated by management. Most of the entities concerned have initiated employment protection plans, including voluntary redundancy and in-placement schemes...
Nasdaq GlobeNewswire
30/09/2024

Social support becomes lifeline for health amid financial strain

The report highlights key vitality differences across demographics. Men report higher vitality than women, whose scores have significantly declined since 2023. Among generations, baby boomers have the highest vitality, followed by millennials, and Gen Z, while Gen X reports the lowest score. Millennials also experienced a notable decline in vitality compared to last year. The report highlights key vitality differences across demographics. Men report higher vitality than women, whose scores…
PR Newswire
30/09/2024

Desktop Humidor Market Size to Grow USD 197 Million by 2030 at a CAGR of 4.3% |…

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-6E14235/Global_Desktop_Humidor_Market Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-6E14235/Global_Desktop_Humidor_Market Major Factors Driving the Growth of Desktop Humidor Market The global desktop humidor market is growing as cigar enthusiasts and collectors increasingly prioritize proper cigar storage to maintain quality and freshness. Desktop humidors are specialized containers...
PR Newswire
30/09/2024

Bristol Myers Squibb Marks 10 Years of Global Patient Week with Community…

Commenting on the initiative, Her Highness Sheikha Sheikha Bint Saif Al Nahyan, Chairperson of the Emirates Thalassemia Society, said: "We commend Bristol Myers Squibb for organizing this significant blood donation drive as part of their Global Patient Week. Blood donors play an indispensable role in the fight against thalassemia and other blood disorders. Their generosity not only saves lives but also brings hope and relief to countless families facing the challenges of these conditions…
PR Newswire
30/09/2024

Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables…

"This expansion represents a strategic investment in the future of Piramal Pharma Ltd. Filling the commercial manufacturing gap enables the Lexington site to access the rapidly expanding injectables market and establish itself as a key player in the segment," said Nandini Piramal, Chairperson, Piramal Pharma Ltd. "This expansion represents a strategic investment in the future of Piramal Pharma Ltd. Filling the commercial manufacturing gap enables theLexingtonsite to access the…
PR Newswire
30/09/2024

Total number of shares and voting rights in Zealand Pharma A/S on September 30…

Company announcement – No. 46 / 2024 Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024 Copenhagen, Denmark, September 30, 2024–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company...
Nasdaq GlobeNewswire
30/09/2024

SONGMICS HOME Supports Jugendrotkreuz's Milestone Event to Promote First Aid and…

Daisy Wei, Senior Brand Manager of SONGMICS HOME, highlighted that partnering with Jugendrotkreuz represents a significant opportunity to promote first aid skills and the values of volunteer service. This initiative seeks to benefit more individuals, working together toward a better tomorrow. Daisy Wei, Senior Brand Manager of SONGMICS HOME, highlighted that partnering with Jugendrotkreuz represents a significant opportunity to promote first aid skills and the values of volunteer service...
PR Newswire
30/09/2024

ACL Graft Market to Hit USD 0.18 Billion by 2029 with 7.2% CAGR |…

Browse in-depth TOC on "ACL Graft Market" Browse in-depth TOC on "ACL Graft Market" 234 - Tables 36 - Figures 209 - Pages The primary ACL reconstruction and ACL revision segments of the global ACL graft market are based on the type of ACL surgery. With a majority share, the ACL revision category led the ACL graft market in 2023. The demand for ACL grafts is expected to expand as the number of ACL reconstruction failures increases and there is a greater need for better…
PR Newswire
30/09/2024

LABCONNECT APPOINTS WESLEY P. WHEELER AS CHIEF EXECUTIVE OFFICER AND DIRECTOR

"Wes's deep industry knowledge and experience make him the perfect fit for LabConnect," said Tim Johnson, LabConnect's Chairman and Partner at BroadOak Capital. "We are thrilled to welcome him to the team and confident that he will lead the company to even greater achievements." "Wes's deep industry knowledge and experience make him the perfect fit for LabConnect," said Tim Johnson, LabConnect's Chairman and Partner at BroadOak Capital. "We are thrilled to…
PR Newswire
30/09/2024

Grünenthal appoints Dr. Jan Adams as Chief Commercial Officer

Jan Adams succeeds Janneke van der Kamp, who will leave Grünenthal to pursue an opportunity outside the company. Jan AdamssucceedsJanneke van der Kamp, who will leave Grünenthal to pursue an opportunity outside the company. About Grünenthal Grünenthal is a global leader in pain management and related diseases. As a science-based, fully integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients...
PR Newswire
30/09/2024

IGI Announces CRADA with National Cancer Institute to Test Proprietary Oral…

Casitas B-lineage lymphoma b (Cbl/b) is an E3 ubiquitin ligase that has been shown to be a key regulator of the activation of T and natural killer (NK) cells in the absence of CD28 costimulationGRC 65327 has been identified by IGI as a novel, nanomolar potent, selective, and orally bioavailable Cbl/b inhibitor NEW YORK, Sept.30, 2024(GLOBE NEWSWIRE) -- Ichnos Glenmark Innovation (IGI), an alliance between Ichnos Sciences Inc., a global fully integrated clinical-stage...
Nasdaq GlobeNewswire
30/09/2024

Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 30 September 2024– On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under…
Nasdaq GlobeNewswire
30/09/2024

Buyback of Class B shares in Essity during week 39, 2024

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. Class B shares in Essity were repurchased as follows: All purchases...
PR Newswire
30/09/2024

Digital & Intelligent Pathway: Xiaohongshu and VOGUE Business Unveil…

Xiaohongshu, a trendsetting hub for brands to gain popularity, boasts a vast young consumer base and a high-quality content ecosystem. With deep insights into industry trends and user preferences, it has become the premier marketing platform for brands seeking to forge emotional connections with Chinese consumers. Xiaohongshu, a trendsetting hub for brands to gain popularity, boasts a vast young consumer base and a high-quality content ecosystem. With deep insights into industry trends and…
PR Newswire
30/09/2024

Xiaohongshu x VOGUE Business Unveils New Horizons in Healthcare and Wellness at…

Today, Xiaohongshu has established itself as a hub for sharing healthy lifestyles and a comprehensive resource for wellness enthusiasts. With a vibrant community of over 150 million health-conscious users, the social media platform has become a catalyst for trending topics such as skin brightening and anti-aging, healthy weight loss, hair care, nutritional balance, therapeutic exploration, and stress relief, underscoring the shift towards healthy lifestyles and health management, as well as new…
PR Newswire
30/09/2024

Xiaohongshu and VOGUE Business Redefine Home Aesthetics During Milan Fashion…

Aligning perfectly with Xiaohongshu's human-centric values, consumers are increasingly seeking harmony between their home environments and personal lifestyles. As a lifestyle community beloved by youth, the social media platform excels in understanding people's needs, gaining insights into emerging consumer scenarios and industry trends in China. According to Xiaohongshu Research, as of Q2 2024, with a monthly active user base of 300 million, nearly 65% of whom are passionate about home life…
PR Newswire
30/09/2024

SIFI announces allowance of patent on polihexanide for Europe and commercial…

The Patent grant follows SIFI's findings in the Phase 3 clinical trial, where AKANTIOR® (polihexanide 0.08%) demonstrated an 86% clinical resolution rate in AK, with an average time-to-cure of approximately 4 months. The Patent also covers the novel dosing regimen of 16 drops/day for first 5 days, 8 drops/day for the following 7 days, 6 drops/day for the following 7 days and 4 drops/day until clinical resolution. The proven dosing regimen represents also a major improvement in patients' quality…
PR Newswire
30/09/2024

Orion's near-term climate targets approved by the Science Based Targets…

ORION CORPORATION PRESS RELEASE 30 SEPTEMBER 2024 at 10.00 a.m. EEST Orion's near-term climate targets approved by the Science Based Targets initiative Orion Corporation is proud to announce that the Science Based Targets initiative (SBTi) has validated our near-term science-based targets. This means that our greenhouse gas (GHG) emissions reduction targets align with the latest climate science to limit global warming to 1.5°C above pre-industrial levels. Orion Corporation commitsto...
Nasdaq GlobeNewswire
30/09/2024

Change in number of shares and votes in Immunovia AB (publ)

Karin Almqvist Liwendahl, CFOkarin.almqvist.liwendahl@immunovia.com +46 70 911 56 08 Karin Almqvist Liwendahl, CFOkarin.almqvist.liwendahl@immunovia.com +46 70 911 56 08 This information is such information that Immunovia AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact persons set out above, on 30 September 2024 at08:30 CET. Immunovia in brief Immunovia...
PR Newswire
30/09/2024

New number of shares and votes in Sobi

Sobi® is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases. Providing reliable access to innovative medicines in the areas of haematology, immunology and specialty care, Sobi has approximately 1,800 employees across Europe, North America, the Middle East, Asia and Australia. In 2023, revenue amounted to SEK 22.1 billion. Sobi's share (STO: SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn…
PR Newswire
30/09/2024
Altri  Comunicati